Keywords
MedicineMeta-analysisDapagliflozinType 2 diabetesAdverse effectMyocardial infarctionRelative riskCochrane LibraryInternal medicineStroke (engine)Diabetes mellitusMEDLINEAnginaIntensive care medicineConfidence intervalEndocrinology
Affiliated Institutions
Related Publications
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
The magnitude of effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on specific cardiovascular and renal outcomes and whether heterogeneity is based on key baseline ch...
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycemia, based on...
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through ...
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
Despite current established therapy, heart failure (HF) remains a leading cause of hospitalization and mortality worldwide. Novel therapeutic targets are therefore needed to imp...
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperg...
Publication Info
- Year
- 2016
- Type
- review
- Volume
- 4
- Issue
- 5
- Pages
- 411-419
- Citations
- 455
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
455
OpenAlex
Cite This
Jason Wu,
Celine Foote,
Juuso Blomster
et al.
(2016).
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.
The Lancet Diabetes & Endocrinology
, 4
(5)
, 411-419.
https://doi.org/10.1016/s2213-8587(16)00052-8
Identifiers
- DOI
- 10.1016/s2213-8587(16)00052-8